Principles of Interoperability of Diabetes Devices

Abstract

Introduction:

Better interoperability is essential to derive maximum benefit from connected wireless diabetes devices. The need for this feature of diabetes devices is supported by trends in designing better performance for three types of devices: nonmedical devices, medical devices, and diabetes devices.

Framework:

First, interoperability is a standard attribute for the performance of nonmedical devices contained in smart systems that can sense and actuate. Second, interoperability is now mandated by the US Department of Health and Human Services as carried out by the Office of the National Coordinator for Health Information technology (ONC) and the US Food and Drug Administration (FDA) to improve the performance of all medical devices. Third, new guidance from the FDA and nongovernmental professional organizations are intended to promote interoperability because this feature will improve the performance of all diabetes devices.

Recommendations:

Wireless devices perform best when they are interoperable, and this is particularly true for diabetes devices.

Keywords

devices diabetes interoperability performance wireless

Get full access to this article

View all access options for this article.

References

Jendle

Adolfsson

Choudhary

, et al. A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective. Diabetologia. 2024;67(2):236-245. doi:10.1007/s00125-023-06049-5.

Mathkor

Bassfar

, et al. Multirole of the internet of medical things (IoMT) in biomedical systems for managing smart healthcare systems: an overview of current and future innovative trends. J Infect Public Health. 2024;17(4):559-572. doi:10.1016/j.jiph.2024.01.013.

Health Centre for Excellence. Medical device interoperability. FDA. https://www.fda.gov/medical-devices/digital-health-center-excellence/medical-device-interoperability. Published May 16, 2023. Accessed February 22, 2024.

Merging worlds: how EMR integration & remote patient monitoring empower healthcare. BusinessMole. https://www.businessmole.com/merging-worlds-how-emr-integration-remote-patient-monitoring-empower-healthcare/. Published April 17, 2023. Accessed February 22, 2024.

Scott

. Diagnostic Data Without a Home: From continuous glucose monitors to consumer wearables, data abounds without a path to electronic medical records. Association for Diagnostics & Laboratory Medicine. https://www.myadlm.org/cln/articles/2023/june/diagnostic-data-without-a-home. Published June 1, 2023. Accessed February 22, 2023.

Center for Devices and Radiological Health. Design considerations and pre-market submission recommendations for interoperable medical devices. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/design-considerations-and-pre-market-submission-recommendations-interoperable-medical-devices. Published February 19, 2019. Accessed February 22, 2024.

About ONC. HealthIT.gov. https://www.healthit.gov/topic/about-onc. Accessed February 22, 2024.

Trusted Exchange Framework and Common Agreement (TEFCA). HealthIT.gov. https://www.healthit.gov/topic/interoperability/policy/trusted-exchange-framework-and-common-agreement-tefca. Accessed February 22, 2024.

What is FHIR? https://www.healthit.gov/sites/default/files/2019-08/ONCFHIRFSWhatIsFHIR.pdf. Accessed February 22, 2024.

10.

Affairs (ASPA). HHS expands TEFCA by adding two additional QHINs. https://www.hhs.gov/about/news/2024/02/12/hhs-expands-tefca-by-adding-two-additional-qhins.html. Published February 12, 2024. Accessed February 22, 2024.

11.

Health data, technology, and interoperability: certification program updates, algorithm transparency, and information sharing (HTI-1) final rule. HealthIT.gov. https://www.healthit.gov/topic/laws-regulation-and-policy/health-data-technology-and-interoperability-certification-program. Accessed February 22, 2024.

12.

Cures Act Final rule: United States core for interoperability. https://www.healthit.gov/sites/default/files/page2/2020-03/USCDI.pdf. Accessed February 22, 2024.

13.

Commissioner of the FDA. FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices. FDA. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-interoperable-insulin-pump-intended-allow-patients-customize-treatment-through. Published March 24, 2020. Accessed February 22, 2024.

14.

Major milestone in communications standards for diabetes devices. https://www.newswise.com/articles/major-milestone-in-communications-standards-for-diabetes-devices. Accessed April 11, 2024.

15.

IEEE Standard—health informatics: device interoperability part 10425: personal health device communication–device specialization–continuous glucose monitor (CGM). IEEE Standards Association. https://standards.ieee.org. Accessed April 11, 2024.

16.

Commissioner of the FDA. FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices. FDA. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-fully-interoperable-continuous-glucose-monitoring-system-streamlines-review. Published March 24, 2020. Accessed February 22, 2024.

17.

Commissioner of the FDA. FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system. FDA. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-interoperable-automated-insulin-dosing-controller-designed-allow-more-choices. Published March 24, 2020. Accessed February 22, 2024.

18.

U.S. Food and Drug Administration. Tidepool loop traditional 510(k) premarket notification, K203689. www.accessdata.fda.gov/cdrh_docs/pdf20/K203689.pdf. Published January 23, 2023. Accessed July 26, 2024.

19.

Tidepool loop clearance. https://www.tidepool.org/blog/tidepool-loop-has-received-fda-clearance. Accessed April 11, 2024.

20.

Espinoza

Yeung

Huang

Seley

Longo

Klonoff

DC.

The need for data standards and implementation policies to integrate insulin delivery data into the electronic health record. J Diabetes Sci Technol. 2023;17(5):1376-1386. doi:10.1177/19322968231178549.

21.

Klonoff

Kerr

Mulvaney

, eds. Diabetes Digital Health and Telehealth. Amsterdam, The Netherlands: Elsevier; 2020.

22.

Espinoza

Klonoff

Vidmar

, et al. 2022 iCoDE report: CGM-EHR integration standards and recommendations. https://www.diabetestechnology.org/icode/. Published November 7, 2022. Accessed January 17, 2023.

23.

iCoDE Standard Project. iCoDE standard project. https://www.diabetestechnology.org/icode/. Accessed July 26, 2024.

24.

Aaron

Tian

Yeung

Huang

Klonoff

Espinoza

JC.

The launch of the iCoDE-2 standard project: integration of connected diabetes device data into the electronic health record. J Diabetes Sci Technol. 2024;18(1):82-88. doi:10.1177/19322968231207888.

25.

Gruson

Cobbaert

Dabla

, et al. Validation and verification framework and data integration of biosensors and in vitro diagnostic devices: a position statement of the IFCC Committee on Mobile Health and Bioengineering in Laboratory Medicine (C-MBHLM) and the IFCC Scientific Division [published online ahead of print February 21, 2024]. Clin Chem Lab Med. doi:10.1515/cclm-2023-1455.

26.

Greene

. Taking the pulse of data and technology in modern healthcare. Arcadia. https://arcadia.io/resources/taking-the-pulse-of-data-and-technology-in-modern-healthcare. Published September 6, 2023. Accessed February 22, 2024.

27.

ARCADIA. Report: only 57% of healthcare organizations’ data is used to make decisions. https://www.prnewswire.com/news-releases/report-only-57-of-healthcare-organizations-data-is-used-to-make-decisions-301886374.html. Accessed February 22, 2024.